Living Made Easier

COMPOSITION:

• Glatix-M: Gliclazide 40 mg + Metformin HCI 500 mg
• Glatix-M80: Gliclazide 80 mg + Metformin HCI 500 mg

• Inhibits the increased adhesiveness of diabetic monocytes to endothelial cells and reduces the production of TNF-alpha.
• Improved glycemic control and aids in protection of both micro vascular and macro vascular complications.
• Safe and potent drug especially in patients with Ischemic heart disease.

INDICATIONS:

• Type-II Diabetes Millitus

GLATIX-M Tablets

• Sulfonylurea (insulin secretagogues)
• Effectively lowers the level of glycated hemoglobin (HbA1c) across a broad range of patients with type 2 diabetes.
• Possesses antioxidant properties, reduces markers of endothelial inflammation, and prevents glucose-induced apoptosis of endothelial cells.

Metformin

• Drug class: Biguanides
• Potent antihyperglycaemic agent for type 2 diabetes that efficiently decreases hepatic glucose production.
• Safe for normal to obese type 2 diabetes patients.
• Metformin (MET) is widely considered to be the best first step in oral antidiabetic treatment, not only because of its efficacy in reducing the glycosylated hemoglobin A_1c (HbA_1c), but also due to its low risk for hypoglycemia, its positive or neutral effect on body weight, its rare incidence of adverse effects, and its low cost.